A voluntary agreement between the Government and the pharmaceutical industry.
The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines.
The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have welcomed the publication of "Continuity in the availability of goods for the EU and the UK", published today by the UK Government's Department for Exiting the European Union.
As a membership organisation we work with our member companies, and the expertise of the specialists they employ, to develop and present our points of view to UK and European governments, the public and to other stakeholders.
Ex-ABPI president Nigel Brooksby has recently written an article for 'Clinical Discovery' called 'Clinical Research - Innovation: Now is the right time to get it right for skills'
The article discusses the UK environment for clinical research and development and the innovation in skill development that is needed to support the UK clinical R&D ambitions.
To read the article please visit the Clinical Discovery website at http://www.clinicaldiscovery.com/readArticle.aspx?articleId=188